Iqvia collaborating with janssen research & development on their investigational covid-19 vaccine trials

Danbury, conn. & research triangle park, n.c--(business wire)--iqvia™ (nyse: iqv) announces that since september 2020 it has been collaborating with janssen research & development, llc, one of the janssen pharmaceutical companies of johnson & johnson, on the phase 3 covid-19 vaccine clinical trials. the studies leverage iqvia's suite of decentralized trial solutions that support both on-site and remote study delivery through a mix of telehealth technologies, virtual oversight, and digit
IQV Ratings Summary
IQV Quant Ranking